Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 7837
Country/Region: Botswana
Year: 2008
Main Partner: KNCV Tuberculosis Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $423,000

Funding for Care: TB/HIV (HVTB): $423,000

08.C0704 TB Control Assistance Program

TBCAP is a USAID five year cooperative agreement awarded to the TBCTA with the KNCV Tuberculosis

Foundation as the lead partner. TBCTA is a coalition of eight well-known international organizations in TB

control: American Thoracic Society (ATS), CDC, Family Health International (FHI), International Union

Against Tuberculosis and Lung Disease (The UNION), Japanese Anti-Tuberculosis Association (JATA),

Royal Netherlands Tuberculosis Foundation (KNCV), Management Sciences for Health (MSH) and World

Health Organization (WHO). TBCTA was created in 2000 and is the United States Agency for International

Development (USAID) Bureau for Global Health's lead technical assistance partner in accelerating the

implementation and expansion of TB control strategies in developing countries.

TB CAP focuses on five priority areas: 1) increasing political commitment for the DOTS strategy; 2)

strengthening and expanding DOTS programs; 3) increasing public and private sector partnerships; 4)

strengthening TB and HIV/AIDS collaboration; 5) improving human and institutional capacity.

Some of the major recommendations of the 2006 comprehensive program review concerned TB/HIV

collaboration, prevention and management of multidrug-resistant TB (MDR-TB), and development and

strengthening of partnerships with all care providers. The BNTP is currently overstretched and is unable to

fully address these issues, resulting in sub-optimal implementation of national TB control policies and

reduced absorption of funds. TBCAP expertise will complement national efforts to achieve Millennium

Development Goals (MDGs) and PEPFAR goals for TB control.

2008 Plans

COP08 funds will strengthen the human resource base for TB control activities by supporting the salaries

and benefits for one medical officer (TB/HIV advisor) seconded to the BNTP, one senior laboratory scientist

for the NTRL and a laboratory technologist to be seconded to NRH laboratory, and the administrative costs

associated with these posts, at a cost of $332,150. The TB/HIV advisor will be seconded to work with the

BNTP, with responsibility for overseeing TB/HIV activities within the BNTP and the development and

strengthening of links with HIV/AIDS prevention, treatment, care and support services in both the private

and public sectors. The senior laboratory scientist will act as the laboratory director and mentor the

laboratory scientist appointed by the MOH in the management of a reference laboratory. The candidate will

also provide laboratory technical support to improve TB diagnostic in the country and will guide the

establishment of the second TB culture and DST laboratory capacity in Francistown. The laboratory

technologist will provide the technical support for initiating culture and drug susceptibility testing in

Francistown.

FY08 funding of TBCAP will strengthen DOTS expansion through improving community-based TB/HIV

collaborative activities and in the organization of services to improve the management of multidrug-resistant

TB services.